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Background: Tuberculosis (TB) is a global burden with one –third of the world’s population infected with the
pathogen Mycobacterium tuberculosis complex and annually 1.4 million deaths occur due to the disease. This
high incidence of infection and the increased rate of multi-drug resistant and extensively-drug resistant strains of
the organism further complicated the problem of TB control and have called for an urgent need to develop new
anti-TB drugs from plants. In this study, the in vitro activity of root of Calpurnia aurea, seeds of Ocimum basilicum,
leaves of Artemisia abyssinica, Croton macrostachyus, and Eucalyptus camaldulensis were evaluated against M.
tuberculosis and M. bovis strains.
Methods: Five Ethiopian medicinal plants, root of Calpurnia aurea, seeds of Ocimum basilicum, leaves of Artemisia
abyssinica, Croton macrostachyus, and Eucalyptus camaldulensis used locally for the management of TB. They were
investigated for in vitro antimycobacterial activity against M. tuberculosis and M. bovis strains. 80% methanolic extracts of
the plant materials were obtained by maceration. The antimycobacterial activity was determined using 96 wells
of microplate with the help of visual Resazurin Microtiter Assay.
Results: The crude 80% methanolic extracts of the root of C. aurea, seeds of O. basilicum, and leaves of A. abyssinica,
C. macrostachyus, and E. camaldulensis had anti-mycobacterial activity with minimum inhibitory concentration (MIC)
ranging from 6.25–100 μg/mL. The MIC of 80% methanol extracts in the order mentioned above ranged 25-100 μg/ml
and 12.5-75 μg/mL, 25–100 μg/mL and 25–50 μg/mL, 6.25-50 μg/mL and 12.5-50 μg/mL, 12.5-100 μg/mL and
18.25-50 μg/mL and 6.25-50 μg/mL and 12.5-50 μg/mL, respectively for M. tuberculosis and M. bovis strains.
Conclusions: The results support the local use of these plants in the treatment of TB and it is suggested that these
plants may have therapeutic value in the treatment of TB. However, further investigations are needed on isolating
chemical constituents responsible for eliciting the observed activity in these plants.
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Tuberculosis (TB) is caused by a set of closely related
mycobacterial strains such as Mycobacterium tuberculosis,
M. bovis, M. africanum and others, known collectively as
the M. tuberculosis complex (MTC) [1]. Currently about
one –third of the world’s population is assumed to be
infected with the tubercle bacillus [2,3]. It is responsible
for 1.4 million deaths per a year [4]. Moreover, up to 50* Correspondence: abdgemechu@gmail.com
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reproduction in any medium, provided the ormillion people are said to be infected with drug-resistant
forms of TB from which about 500,000 cases of multi-
drug resistant (MDR) TB worldwide per a year [5].
Management of TB/MDR-TB patient requires intense
multi-chemotherapy for at least six months to two years.
It is very hurtful to a patient’s health due to high levels of
drug toxicity and its adverse effects [6-8]. The emergence
of MDR TB and extensively-drug resistant (XDR) TB to
the medicines now in use makes urgent search for new
anti-TB agents worldwide [9,10]. Medicinal plants offer a
great hope to overcome these needs because of their
chemical diversity and their significant role in the drugral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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as a useful source of highly active antimycobacterial
metabolites [12].
In Ethiopia there are many plant species reported to
be used traditionally to treat TB and respiratory tract
infections. For instances, leaves and fruits of Allium
ursinum were locally used for the treatment of bronchitis
and TB respectively in Central Zone of Tigray [13]. It
was also reported that locally available plant species
such as Croton macrostachyus and Oenanthe procumbens
in Farta wereda of Amhara region [14] and Arisaema
schimperianum around Bale mountains national park [15]
are to used to treat TB respectively. Likewise, roots of
Calpurnia aurea are used for lung TB [16]. Additionally it
was reported that fruits/seeds of Ocimum basilicum and
Ocimum americanum, leaves of Eucalyptus camaldulensis,
Artemisia afra and Artemisia abyssinica are used for
cough and TB [17]. Leaves of Aloe pubescens, root of
Indigofera amorphoides and Psydrax schimperiana are
reported to be some of the medicinal plants locally
used to treat TB and other respiratory illness and other
diseases [18]. Moreover, in Chifra District, Afar region,
it was reported that Kanahia laniflora and Aloe species
were locally used for treatment of TB [19]. However,
their efficacy remains unknown. Thus, the aim of this
study was to evaluate the in vitro anti-mycobacterial
activity of root of Calpurnia aurea, seeds Ocimum
basilicum, leaves of Artemisia abyssinica, Croton
macrostachyus, and Eucalyptus camaldulensis against
M. tuberculosis and M. bovis strains.Methods
Study design
This study was conducted at Aklilu Lemma Institute of
Pathobiology (ALIPB), Addis Ababa University (AAU)
using an experimental study design. Five plant species,
namely C. aurea, O. basilicum, A. abyssinica, C. macro-
stachyus, and E. camaldulensis were selected for their
in vitro activity test against M. tuberculosis and M. bovis
strains. Susceptibility tests and MIC of the extracts were
determined using Resazurin Microtiter Assay (REMA).
Rifampicin was used as positive control while drug and
extract free medium were used as negative controls.Table 1 Medicinal plants used for antimycobacterial activity a
bovis strains
Plant species Family Vernacular name
Ocimum basilicum Lamiaceae Basobila (Amharic (Amh
Croton macrostachyus Euphorbiaceae Bisana (Amh)
Calpurnia aurea Leguminosae Digitta (Amh)
Eucalyptus camaldulensis Myrtaceae Key bahirzaf (Amh)
Artemisia abyssinica Asteraceae Chikugn (Amh)Collection of plants materials
The leaves of C. macrostachyus, roots of C. aurea, and
seeds of O. basilicum were collected from Addis Ababa.
Leaves of E. camaldulensis, and A. abyssinica were collected
from Harar (525 km East of Addis Ababa) and Muka
Turi (Selale/North Shoa Zone) 80 km north of Addis
Ababa, respectively (Table 1). The identities of each plant
specimen were identified by Dr. Mirutse Giday (a botanist)
at the Endod and Other Medicinal Plants Research Unit,
ALIPB. A voucher specimen of each plant was deposited
at the Endod and Other Medicinal Plants Research Unit,
with voucher numbers AG-01 (O. basilicum), AG-02
(C. macrostachyus), AG-03 (C. aurea), AG-04 (E. camal
dulensis), and AG- 05 (A. abyssinica). All parts of the plant
materials were made to become dry in an open air and
protected from direct exposure to sunlight. The dried
plant materials were separately powdered to suitable
size by using mortar and pestle, and then made ready
for extraction.
Preparation of the extract
The powdered plant materials were weighed using ana-
lytical balance and prepared for solvent extraction. The
crude 80% methanolic extracts of the plant materials
were obtained by maceration. The total crude 80%
methanolic extracts were obtained by soaking powdered
plant material (about 50 g) in 400 mL methanol for 48–
72 h on an orbital shaker [20]. Extracts were filtered using
Whatman No.1 filter paper and concentrated using a ro-
tary evaporator (Laborota 4000, SN 090816862, Germany)
in a water bath set at 40°C. The dried methanolic extracts
obtained from each plant were air-dried then packed in
glass bottles with proper labeling for future reference.
The extracts were kept refrigerated and far away from
light. Stock solutions were prepared in dimethyl sul-
phoxide (DMSO) at a concentration of 20 mg/mL and
stored at −20°C until use [20,21]. Finally, all the crude
80% methanolic extracts of each plant species were
tested for antimycobacterial activity.
Test organisms
M. tuberculosis strains including (H37Rv, SIT777, SIT73,
SIT26, SIT37, SIT1688, SIT336, SIT149, SIT53, and
SIT54) and M. bovis strains (SB1176, SB1953 and SB0133)gainst Mycobacterium tuberculosis and Mycobacterium
Parts used Voucher specimen Place of collection
)) Seeds AG-01 AA (from market)
Leaves AG-02 ALIPB compound
Roots AG-03 ALIPB compound
Leaves AG-04 Harar
Leaves AG-05 Muka Turi
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used for evaluation of plants crude extracts.
Preparation of Inoculum
The isolates grown on Lowenstein Jensen medium (LJ)
were sub-cultured in Middle Brook 7H9 broth supple-
mented with OADC at 37°C for 14 – 21 days. The anti-
mycobacterial activities of the extracts were evaluated
against ten M. tuberculosis strains and three M. bovis
strains by maintaining on Middle Brook 7H9 medium
for about 14–21 days. The bacterial suspension was
homogenized by vortex shakeup and the turbidity was
adjusted in agreement with tube which is the scales of
McFarland no.1 (3.2 × 106 cfu/mL). The inoculum was
prepared diluting the bacterial suspension in the pro-
portion of 1:20 in Middle Brook 7H9 broth medium.
This diluted suspension (100 μL) was used to inoculate
each well of the plate [22].
Anti-mycobacterial activity tests
The antimycobacterial activity of 80% methanolic crude
extracts of O. basilicum seeds, C. aurea root, C. macro
stachyus, A. abyssinica and E. camaldulensis leaves were
tested using the REMA. The susceptibility test was
accomplished in 96 microplates (wells) using the resazurin
as an indicator of cellular viability or growth inhibition.
Working solutions of the tested extracts were diluted
in Middle Brook 7H9 broth supplemented with OADC
to obtain final sample concentrations that ranges from
0.78 μg/mL to 100 μg/mL. Rifampicin was dissolved in
DMSO and used as positive control drug and extracts/
drug free medium with strain suspensions were used as
negative control. One hundred micro liters of Middle
Brook 7H9 broth and the test inoculum were added to
all testing wells, as well as to the drug/extract-free control
wells. Then, one hundred micro liters working extract
solutions were poured into the first well of each row
from which two-fold dilution series were made through
the micro plate column. Each extract concentration was
assayed in duplicate. Each micro plate was then sealed
with parafilm and incubated for 5–7 days at 37°C in
normal atmosphere. After the incubation period, 25 μL
of resazurin 0.02% w/v was added to each wells and re-
incubated at 37°C for 24 h for color development. The
visual MIC was defined as the lowest drug/extract con-
centration that prevented the color change of resazurin
reagent from blue to pink. Blue color in the well was
interpreted as there is no mycobacterial growth and
pink color was scored as growth occurrence [23,24].
Determination of the Minimum Inhibitory
Concentration (MIC)
MIC was determined by using the REMA in 96 well micro
titer plates. One hundred micro liters of Middle Brook7H9 broth and M. tuberculosis and M. bovis strains were
dispensed into all wells of a sterile 96-well microtitre plate.
In the first column (no.1 well of all plate), one hundred
micro liters of extracts were added to each first wells using
a unique pipette for each extracts. The extracts were
mixed thoroughly and fifty micro liters of extracts were
transferred to well 2 to well 8 from which fifty micro
liters were discarded. Well 9 up to well 12 were served
as sterility and negative controls. The working solution
of extracts (100 μg/mL) were diluted out across a 96-
well in a two-fold serial dilution to give final testing
concentrations of 50, 25, 12.5, 6.25, 3.12, 1.56 and
0.78 μg/mL. The same procedure was followed for
rifampicin with the initial concentration of 32 μg/mL
with subsequent dilution to the final testing concentrations
16, 8, 4, 2, 1, 0.5, 0.25, 0.125 and 0.06 μg/mL. The plates
were then incubated for 5–7 days at 37°C. After 7th day,
25 μL of resazurin was added to all wells and re-incubated
overnight for development. The MIC was defined as
the lowest concentration of the extracts/drugs that pre-
vented a colour of resazurin to be changed from blue to
pink (visual determination) [24-27]. According to Ramos
[22], extracts were considered as active if they inhibited
growth of mycobacterium at MIC ≤ 100 μg/mL. Each
extract was tested in duplicate against each strain.
Data analysis
The experimental results were computerized using Epi-
Data version 3.1 and STATA version 11 statistical software
for data entry and analysis purposes respectively. The
MIC results were presented as mean value. The t-test was
employed to test significance for the difference between
80% methanolic extract results of each plant and rifam-
picin against M. tuberculosis and M. bovis strains. All
the data were analyzed at 95% confidence interval and
considered as statistically significant.
Ethical consideration
The study was conducted after its approval by the Insti-
tutional Review Board of ALIPB. The test was done in
the TB laboratory where the necessary protective wears
such as respirators and gloves as well as safety cabinets
were used, to minimize the risk of exposure to M. tuber-
culosis and M. bovis isolates.
Results and discussion
Anti-mycobacterial activity of the crude extracts
Crude 80% methanolic extracts of all the five plants,
namely leaves of C. macrostachyus, seeds of O. basilicum,
root of C. aurea, leaves of E. camaldulensis and A.
abyssinica were screened for their antimycobacterial
activity against M. tuberculosis strains (H37Rv, SIT777,
SIT73, SIT26, SIT37, SIT1688, SIT336 ,SIT149, SIT53,
SIT54) and M. bovis strains (SB1176, SB1953 and SB0133)
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against M. tuberculosis and M. bovis strains with the
mean MIC values ranging from 6.25 to 100 μg/mL. Se-
lective activity of five 80% methanolic crude extracts
and rifampicin against all strains of M. tuberculosis and
M. bovis were observed (Table 2).
Minimum inhibitory concentration
The MIC of the extracts was determined for their anti-
mycobacterial activity using resazurin as an indicator for
M. tuberculosis and M. bovis strains viability in 96-well
microplates. The MIC of 80% methanolic extracts of root
of C. aurea, seeds of O. basilicum, leaves of A. abyssinica,
C. macrostachyus and E. camaldulensis ranged from
25–100 μg/mL and 12.5-75 μg/mL, 25–100 μg/mL and
25–50 μg/mL, 6.25-50 μg/mL and 12.5-50 μg/mL, 12.5-
100 μg/mL and 18.25-50 μg/mL and 6.25-50 μg/mL
and 12.5-50 μg/mL, respectively for M. tuberculosis and
M. bovis strains. The investigation showed that leaves
of E. camaldulensis extract was the most active against
both M. tuberculosis and M. bovis strains (MIC 6.25-
50 μg/mL). The mean MIC results of 80% methanolic
crude extracts of each plant showed significantly lower
antimycobacterial activities in comparison to rifampicin
for all strains (Table 2). Although all extracts were
found less active than rifampicin, extracts of leaves of
A. abyssinica and E. camaldulensis showed interesting
antimycobacterial activity. However, reference strain ofTable 2 Mean of MIC values of 80% methanolic crude
extracts of five medicinal plants against ten M.




name Ob Ca Cm Aa Ec Rif
H37Rv MTB 25 37.5 12.5 6.25 25 2
SIT777 MTB 50 50 100 50 25 4
SIT73 MTB 50 25 25 25 6.25 0.25
SIT26 MTB 75 50 25 50 50 2
SIT37 MTB 100 100 37.5 50 25 3
SIT1688 MTB 100 75 50 50 37.5 2
SIT336 MTB 100 37.5 100 37.5 50 1.5
SIT149 MTB 50 50 25 50 50 0.5
SIT53 MTB 75 75 25 50 50 0.25
SIT54 MTB 75 50 25 50 37.5 3
SB1176 MB 50 50 50 50 25 0.09
SB1953 MB 25 12.5 37.5 12.5 12.5 1
SB0133 MB 37.5 75 25 12.5 50 2
Ob = Ocimum basilicum, Ca = Calpurnia aurea, Cm = Croton macrostachyus,
Aa = Artemisia abyssinica, Ec = Eucalyptus camaldulensis, RIF = Rifampicin,
MTB =M. tuberculosis, MB =M. bovis.M. tuberculosis H37Rv, SIT73, SIT149, SIT149, SB1176 and
SB1953 strains were comparatively the most susceptible
strains to the extracts of the study plants with MIC ≤
50 μg/mL. In contrast, SIT37 and SIT336 strains were
the most resistant to extracts as compared to other strains.
The comparative mean MIC values of plant extracts and
rifampicin against clinical isolates and reference strain of
M. tuberculosis H37Rv and M. bovis strains is shown in
(Table 2).
Despite intense hard work to control TB disease, it
remains one of the global health problems claiming 1.4
million human lives per annum. Furthermore, in the
worldwide up to 50 million people are said to be
infected with drug-resistant forms of TB with about
500,000 cases of multi-drug resistant MDR-TB per a
year [5). Thus, with the emergence of the drug-resistant
strains of MTC, lengthy of therapy, which is very hurtful
to a patient’s health due to high levels of drug toxicity
and its various adverse effects, the need to search for
new effective anti-TB agents has become very necessary.
Using medicinal plants for the treatment of TB offers a
great hope to fulfill these needs because of their chemical
diversity and they have been used for curing diseases
for many centuries [11]. In addition, natural herbs continue
to play a great significant role in the drug discovery
and development of highly active antimycobacterial
metabolites and they can be used as pure compounds
or as crude materials [12].
In Ethiopia, many medicinal plants have been found
which are used in the treatment of microbial infections
including TB. It is our interest to report the anti-TB
activity of these plants since these plants are reported
from communities to treat TB and other respiratory
infections. During ethnobotanical study these plants
had been reported to possess antimicrobial activity. In
the present study, the crude 80% methanol extracts of
seeds of O. basilicum, root of C. aurea, and leaves of
C. macrostachyus, A. abyssinica and E. camaldulensis
showed promising antimycobacterial activity against
M. tuberculosis and M. bovis strains. This may be due
to the bioactive constituents, such as alkaloids, tannins,
saponins, phenols, flavonoids and others that are present
in the extracts [28,29]. Although the antibacterial activ-
ity of O. basilicum, C. aurea, C. macrostachyus, and A.
abyssinica had been reported against other various
pathogenic bacteria [30,31], no report was found during
a literature search against mycobacterium strains apart
from ethnobotanical reports on these plants. Therefore,
this investigation would be the first report on their
anti-mycobacterial activities. The crude 80% methanolic
extracts of leaves of E. camaldulensis exhibited the most
antimycobacterial activity against both M. tuberculosis and
M. bovis strains. This could be due the bioactive tannins
and saponins present in the extracts. This report agrees
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extracts of E. camaldulensis [32,33]. In Ethiopia, the
present work demonstrates antimycobacterial properties
of these plants having therapeutic value in the treatment
of TB. However, it is generally recognized that the more
antimycobacterial activity of extracts depends on their
lipophilic nature and showed better activity [20,34].
Conclusions
Even though this investigation supports the traditional
medicinal usage in the Ethiopian community and the
medicinal uses of these plants in different regions of
Ethiopia; to obtain the most promising antimycobacterial
activity and to conclude their anti-TB activity, these
plants should be fractionated with less polar solvents. In
addition, further investigations should focus on isolating
chemical constituents responsible for pharmacological
activities and identifying the compounds eliciting the
activity observed in these plants.
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